Press Release: Thrasos : Thrasos to Present at the 22nd Annual BioCentury NewsMakers and 8th Annual BioPharm America Conferences

MONTREAL--(BUSINESS WIRE)--Thrasos Therapeutics, a biotherapeutics company focused on delivering new solutions for kidney disease, announced today that it will be participating in two key meetings in September, BioCentury NewsMakers and BioPharm America. Richard Andrews President and Chief Executive Officer will present a company overview at the 22nd Annual BioCentury NewsMakers in the Biotech Industry Conference on Thursday, September 10th. The BioCentury NewsMakers Conference takes place at t